Lotus Health Group Company Logo

Lotus Health Group Company

600186.SS

(2.0)
Stock Price

4,92 CNY

6.4% ROA

11.54% ROE

41.08x PER

Market Cap.

7.326.077.318,00 CNY

28.54% DER

0% Yield

7.69% NPM

Lotus Health Group Company Stock Analysis

Lotus Health Group Company Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Lotus Health Group Company Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (0%), which means it has a small amount of debt compared to the ownership it holds

2 ROE

ROE in an average range (6.27%) suggests satisfactory profitability and decent utilization of shareholders' equity.

3 ROA

The stock's ROA (3.87%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

4 Revenue Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

5 Net Profit Growth

With continuous net profit growth in the past three years, this company demonstrates a strong financial performance, making it an enticing investment opportunity.

6 Assets Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

7 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (160), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

8 PBV

The stock's high Price-to-Book Value (P/BV) ratio (8.64x) suggests it's overvalued, potentially making it an expensive investment.

9 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

10 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

11 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

Lotus Health Group Company Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Lotus Health Group Company Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Lotus Health Group Company Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Lotus Health Group Company Revenue
Year Revenue Growth
1995 1.294.220.615
1996 1.478.323.581 12.45%
1997 1.539.681.296 3.99%
1998 1.220.782.560 -26.12%
1999 1.242.753.927 1.77%
2000 1.310.420.579 5.16%
2001 1.387.501.387 5.56%
2002 1.219.650.095 -13.76%
2003 1.173.550.649 -3.93%
2004 952.165.222 -23.25%
2005 1.337.548.798 28.81%
2006 1.855.718.809 27.92%
2007 2.215.126.364 16.23%
2008 2.051.068.385 -8%
2009 2.478.626.931 17.25%
2010 2.697.881.265 8.13%
2011 2.762.371.787 2.33%
2012 2.542.826.867 -8.63%
2013 2.156.618.606 -17.91%
2014 2.004.938.773 -7.57%
2015 1.776.275.422 -12.87%
2016 1.766.772.730 -0.54%
2017 1.852.912.238 4.65%
2018 1.728.816.962 -7.18%
2019 1.702.510.415 -1.55%
2020 1.654.638.589 -2.89%
2021 1.814.929.608 8.83%
2022 1.691.055.172 -7.33%
2023 2.562.791.235 34.02%
2023 2.100.723.000 -22%
2024 2.580.964.108 18.61%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Lotus Health Group Company Research and Development Expenses
Year Research and Development Expenses Growth
1995 0
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 2.085.799 100%
2013 2.231.600 6.53%
2014 3.188.500 30.01%
2015 3.612.315 11.73%
2016 0 0%
2017 0 0%
2018 0 0%
2019 984.249 100%
2020 17.720.340 94.45%
2021 22.072.411 19.72%
2022 21.557.179 -2.39%
2023 23.337.513 7.63%
2023 28.733.111 18.78%
2024 33.517.804 14.28%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Lotus Health Group Company General and Administrative Expenses
Year General and Administrative Expenses Growth
1995 33.987.733
1996 27.606.542 -23.11%
1997 23.222.306 -18.88%
1998 19.417.551 -19.59%
1999 21.021.954 7.63%
2000 37.000.628 43.18%
2001 55.926.696 33.84%
2002 61.909.698 9.66%
2003 75.799.631 18.32%
2004 66.737.611 -13.58%
2005 62.929.544 -6.05%
2006 52.365.590 -20.17%
2007 116.273.210 54.96%
2008 125.209.832 7.14%
2009 127.467.937 1.77%
2010 55.896.370 -128.04%
2011 52.431.172 -6.61%
2012 45.731.081 -14.65%
2013 56.904.060 19.63%
2014 25.722.075 -121.23%
2015 23.835.802 -7.91%
2016 20.907.082 -14.01%
2017 16.449.026 -27.1%
2018 14.359.863 -14.55%
2019 11.027.511 -30.22%
2020 11.960.917 7.8%
2021 13.920.920 14.08%
2022 10.991.816 -26.65%
2023 199.805.375 94.5%
2023 16.813.710 -1088.35%
2024 -41.676.227 140.34%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Lotus Health Group Company EBITDA
Year EBITDA Growth
1995 99.892.302
1996 148.764.799 32.85%
1997 147.796.170 -0.66%
1998 155.943.187 5.22%
1999 233.776.160 33.29%
2000 366.304.474 36.18%
2001 321.885.964 -13.8%
2002 206.937.898 -55.55%
2003 75.513.211 -174.04%
2004 201.843.593 62.59%
2005 178.214.601 -13.26%
2006 207.804.649 14.24%
2007 -78.606.155 364.36%
2008 -78.676.924 0.09%
2009 422.775.834 118.61%
2010 278.181.900 -51.98%
2011 -126.540.543 319.84%
2012 201.665.176 162.75%
2013 -123.325.550 263.52%
2014 179.105.547 168.86%
2015 -158.872.679 212.74%
2016 207.850.130 176.44%
2017 -90.237.629 330.34%
2018 -188.160.163 52.04%
2019 61.874.049 404.1%
2020 137.545.285 55.02%
2021 83.397.721 -64.93%
2022 89.374.483 6.69%
2023 241.902.001 63.05%
2023 196.839.528 -22.89%
2024 311.896.960 36.89%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Lotus Health Group Company Gross Profit
Year Gross Profit Growth
1995 172.092.343
1996 226.851.160 24.14%
1997 232.359.575 2.37%
1998 191.432.990 -21.38%
1999 257.092.447 25.54%
2000 366.351.972 29.82%
2001 332.018.829 -10.34%
2002 242.954.162 -36.66%
2003 146.825.714 -65.47%
2004 161.207.643 8.92%
2005 173.354.412 7.01%
2006 195.019.287 11.11%
2007 143.740.571 -35.67%
2008 -17.724.058 910.99%
2009 294.383.690 106.02%
2010 151.338.577 -94.52%
2011 6.716.723 -2153.16%
2012 23.376.910 71.27%
2013 51.799.222 54.87%
2014 114.202.823 54.64%
2015 81.967.230 -39.33%
2016 175.964.988 53.42%
2017 200.736.666 12.34%
2018 167.721.398 -19.68%
2019 172.924.333 3.01%
2020 294.791.681 41.34%
2021 223.351.798 -31.99%
2022 238.569.937 6.38%
2023 446.224.652 46.54%
2023 360.176.158 -23.89%
2024 574.318.788 37.29%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Lotus Health Group Company Net Profit
Year Net Profit Growth
1995 51.586.322
1996 55.114.904 6.4%
1997 100.660.134 45.25%
1998 120.325.089 16.34%
1999 168.567.976 28.62%
2000 171.820.687 1.89%
2001 145.409.111 -18.16%
2002 19.324.174 -652.47%
2003 -145.377.078 113.29%
2004 4.604.955 3256.97%
2005 9.724.125 52.64%
2006 21.359.432 54.47%
2007 -175.500.070 112.17%
2008 -302.654.062 42.01%
2009 186.595.993 262.2%
2010 17.584.517 -961.14%
2011 -459.016.467 103.83%
2012 36.570.829 1355.14%
2013 -325.994.657 111.22%
2014 23.869.487 1465.74%
2015 -508.487.025 104.69%
2016 65.247.448 879.32%
2017 -103.432.699 163.08%
2018 -332.530.366 68.9%
2019 28.059.638 1285.08%
2020 74.286.138 62.23%
2021 44.364.370 -67.45%
2022 46.194.706 3.96%
2023 177.732.756 74.01%
2023 129.927.433 -36.79%
2024 206.455.732 37.07%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Lotus Health Group Company Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1995 0
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Lotus Health Group Company Free Cashflow
Year Free Cashflow Growth
1998 -245.416.003
1999 -55.774.747 -340.01%
2000 -195.056.733 71.41%
2001 -339.217.682 42.5%
2002 13.775.185 2562.53%
2003 -275.443.841 105%
2004 -246.332.808 -11.82%
2005 76.117.544 423.62%
2006 17.125.853 -344.46%
2007 17.278.955 0.89%
2008 -9.462.132 282.61%
2009 45.535.756 120.78%
2010 5.658.885 -704.68%
2011 -8.469.646 166.81%
2012 -28.801.428 70.59%
2013 -9.585.056 -200.48%
2014 -72.549.000 86.79%
2015 -6.452.093 -1024.43%
2016 -43.150.543 85.05%
2017 -43.549.638 0.92%
2018 -29.207.453 -49.1%
2019 -97.127.056 69.93%
2020 -884.411.434 89.02%
2021 -31.464.063 -2710.86%
2022 13.397.723 334.85%
2023 -36.125.336 137.09%
2023 -11.814.309 -205.78%
2024 -111.685.107 89.42%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Lotus Health Group Company Operating Cashflow
Year Operating Cashflow Growth
1998 -88.428.922
1999 162.029.118 154.58%
2000 89.054.736 -81.94%
2001 37.135.653 -139.81%
2002 85.130.114 56.38%
2003 -255.472.480 133.32%
2004 -234.075.403 -9.14%
2005 83.191.502 381.37%
2006 23.101.699 -260.11%
2007 25.822.782 10.54%
2008 -268.599 9713.91%
2009 66.524.707 100.4%
2010 66.503.978 -0.03%
2011 14.415.213 -361.35%
2012 27.850.761 48.24%
2013 71.161.567 60.86%
2014 -38.708.861 283.84%
2015 5.151.676 851.38%
2016 -30.209.699 117.05%
2017 -31.281.206 3.43%
2018 -24.097.844 -29.81%
2019 -95.910.673 74.87%
2020 -794.229.165 87.92%
2021 70.048.794 1233.82%
2022 54.967.206 -27.44%
2023 74.020.658 25.74%
2023 0 0%
2024 63.327.938 100%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Lotus Health Group Company Capital Expenditure
Year Capital Expenditure Growth
1998 156.987.081
1999 217.803.865 27.92%
2000 284.111.469 23.34%
2001 376.353.335 24.51%
2002 71.354.928 -427.44%
2003 19.971.361 -257.29%
2004 12.257.405 -62.93%
2005 7.073.957 -73.28%
2006 5.975.845 -18.38%
2007 8.543.827 30.06%
2008 9.193.534 7.07%
2009 20.988.951 56.2%
2010 60.845.092 65.5%
2011 22.884.859 -165.87%
2012 56.652.189 59.6%
2013 80.746.623 29.84%
2014 33.840.139 -138.61%
2015 11.603.769 -191.63%
2016 12.940.843 10.33%
2017 12.268.432 -5.48%
2018 5.109.609 -140.11%
2019 1.216.383 -320.07%
2020 90.182.269 98.65%
2021 101.512.857 11.16%
2022 41.569.482 -144.2%
2023 110.145.994 62.26%
2023 11.814.309 -832.31%
2024 175.013.045 93.25%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Lotus Health Group Company Equity
Year Equity Growth
1995 247.851.661
1996 267.702.836 7.42%
1997 308.759.679 13.3%
1998 1.139.526.468 72.9%
1999 1.275.393.225 10.65%
2000 1.447.213.913 11.87%
2001 2.065.057.701 29.92%
2002 2.102.022.047 1.76%
2003 1.959.860.106 -7.25%
2004 1.958.152.757 -0.09%
2005 1.962.819.144 0.24%
2006 1.559.611.619 -25.85%
2007 1.410.373.347 -10.58%
2008 1.107.647.026 -27.33%
2009 1.294.252.519 14.42%
2010 1.316.427.769 1.68%
2011 854.273.818 -54.1%
2012 892.180.190 4.25%
2013 553.921.442 -61.07%
2014 558.651.555 0.85%
2015 12.000.892 -4555.08%
2016 29.828.634 59.77%
2017 -110.780.640 126.93%
2018 -494.919.907 77.62%
2019 73.567.961 772.74%
2020 150.960.507 51.27%
2021 1.170.090.470 87.1%
2022 1.177.544.776 0.63%
2023 1.263.902.818 6.83%
2023 1.328.294.634 4.85%
2024 1.430.729.206 7.16%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Lotus Health Group Company Assets
Year Assets Growth
1995 725.125.262
1996 881.248.640 17.72%
1997 1.020.045.210 13.61%
1998 1.770.309.202 42.38%
1999 2.518.917.125 29.72%
2000 3.101.705.633 18.79%
2001 4.325.624.301 28.29%
2002 4.608.384.585 6.14%
2003 4.652.993.995 0.96%
2004 4.487.676.890 -3.68%
2005 4.275.077.950 -4.97%
2006 3.841.824.101 -11.28%
2007 3.798.306.537 -1.15%
2008 3.483.251.476 -9.04%
2009 3.576.999.873 2.62%
2010 3.276.720.895 -9.16%
2011 2.948.518.529 -11.13%
2012 2.813.941.746 -4.78%
2013 2.603.752.550 -8.07%
2014 2.636.258.054 1.23%
2015 2.245.535.861 -17.4%
2016 2.075.509.884 -8.19%
2017 1.889.231.700 -9.86%
2018 1.708.542.518 -10.58%
2019 2.152.656.203 20.63%
2020 1.503.783.979 -43.15%
2021 2.263.654.921 33.57%
2022 2.427.357.984 6.74%
2023 2.462.376.104 1.42%
2023 2.435.684.057 -1.1%
2024 2.939.720.156 17.15%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Lotus Health Group Company Liabilities
Year Liabilities Growth
1995 477.273.600
1996 613.545.804 22.21%
1997 711.285.531 13.74%
1998 630.782.733 -12.76%
1999 1.243.523.899 49.27%
2000 1.654.491.720 24.84%
2001 2.260.566.600 26.81%
2002 2.506.362.538 9.81%
2003 2.693.133.888 6.94%
2004 2.529.524.132 -6.47%
2005 2.312.258.805 -9.4%
2006 2.282.212.482 -1.32%
2007 2.387.933.190 4.43%
2008 2.375.604.449 -0.52%
2009 2.282.747.353 -4.07%
2010 1.960.293.125 -16.45%
2011 2.094.244.710 6.4%
2012 1.921.761.556 -8.98%
2013 2.049.831.107 6.25%
2014 2.077.606.498 1.34%
2015 2.233.534.968 6.98%
2016 2.045.681.249 -9.18%
2017 2.000.012.340 -2.28%
2018 2.203.462.424 9.23%
2019 2.079.088.241 -5.98%
2020 1.352.823.471 -53.69%
2021 1.093.564.451 -23.71%
2022 1.249.813.207 12.5%
2023 1.198.473.286 -4.28%
2023 1.107.389.422 -8.23%
2024 1.508.990.950 26.61%

Lotus Health Group Company Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1.31
Net Income per Share
0.1
Price to Earning Ratio
41.08x
Price To Sales Ratio
3.12x
POCF Ratio
26.49
PFCF Ratio
-38.31
Price to Book Ratio
4.53
EV to Sales
2.7
EV Over EBITDA
24.57
EV to Operating CashFlow
22.68
EV to FreeCashFlow
-33.22
Earnings Yield
0.02
FreeCashFlow Yield
-0.03
Market Cap
7,33 Bil.
Enterprise Value
6,35 Bil.
Graham Number
1.44
Graham NetNet
0.07

Income Statement Metrics

Net Income per Share
0.1
Income Quality
1.57
ROE
0.12
Return On Assets
0.06
Return On Capital Employed
0.15
Net Income per EBT
0.74
EBT Per Ebit
0.89
Ebit per Revenue
0.12
Effective Tax Rate
0.27

Margins

Sales, General, & Administrative to Revenue
0.01
Research & Developement to Revenue
0.01
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.21
Operating Profit Margin
0.12
Pretax Profit Margin
0.1
Net Profit Margin
0.08

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0.06
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.16
Free CashFlow per Share
-0.11
Capex to Operating CashFlow
1.68
Capex to Revenue
0.2
Capex to Depreciation
15.72
Return on Invested Capital
0.09
Return on Tangible Assets
0.06
Days Sales Outstanding
32.81
Days Payables Outstanding
126.69
Days of Inventory on Hand
19.28
Receivables Turnover
11.12
Payables Turnover
2.88
Inventory Turnover
18.94
Capex per Share
0.26

Balance Sheet

Cash per Share
0,80
Book Value per Share
0,80
Tangible Book Value per Share
0.73
Shareholders Equity per Share
0.91
Interest Debt per Share
0.27
Debt to Equity
0.29
Debt to Assets
0.16
Net Debt to EBITDA
-3.76
Current Ratio
1.63
Tangible Asset Value
1,31 Bil.
Net Current Asset Value
0,33 Bil.
Invested Capital
1512562585
Working Capital
0,71 Bil.
Intangibles to Total Assets
0.04
Average Receivables
0,26 Bil.
Average Payables
0,62 Bil.
Average Inventory
94158011.5
Debt to Market Cap
0.06

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Lotus Health Group Company Dividends
Year Dividends Growth
2002 0

Lotus Health Group Company Profile

About Lotus Health Group Company

Lotus Health Group Company engages in the production and sale of healthy condiments and foods in China. The company offers louts mono sodium glutamate, starch/potato/corn, and chicken bouillon. It also provides healthy oil, energy drink, healthy snack, flour, rice, and pasta products. The company was formerly known as Lotus Health Industry Holding Group Company. Lotus Health Group Company was founded in 1983 and is based in Xiangcheng, China.

CEO
Mr. Tao Li
Employee
1.355
Address
No.18 Lianhua Avenue
Xiangcheng, 466200

Lotus Health Group Company Executives & BODs

Lotus Health Group Company Executives & BODs
# Name Age
1 Mr. Tao Li
Co-President
70
2 Mr. Jin Rui Wang
Assistant to the President
70
3 Mr. Xian Hui Luo
Vice President, Secretary & Director
70
4 Mr. Songfeng Yang
Assistant to the President
70
5 Mr. Haifeng Li
Vice President
70
6 Mr. Jiasheng Cao
President & Director
70
7 Mr. Teng Yu
Vice President & Supervisor
70

Lotus Health Group Company Competitors